SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.38-9.0%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOEBT1 who wrote (409)10/1/1999 1:30:00 AM
From: Vector1  Read Replies (1) of 52153
 
JOEBT1,
To follow up on PBs answer I do not think tissue absorption is a major issue or a pacing item. It is my understanding the CLTR had done all of this work and it is simply a matter of putting it in the format the FDA wants. I guess I should not say simply. PBs web site has some excellent links. Reading the abstracts again reconfirm my belief that Bex is an approvable drug that will generate significant sales.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News